cystic fibrosis

Vertex's (VRTX) Trikafta NDA Gets Priority Review by FDA
Vertex's (VRTX) Trikafta NDA Gets Priority Review by FDA
Yahoo/Zacks.com
Vertex Pharmaceuticals
cystic fibrosis
priority revies
FDA
Trikafta
Flag link:
Savara says sayonara to pipeline programs, doubles down on Molgradex, cuts staff
Savara says sayonara to pipeline programs, doubles down on Molgradex, cuts staff
Fierce Biotech
Savara
molgradex
layoffs
cystic fibrosis
Flag link:
Vertex urged to address 'fatal inequality' in access to its cystic fibrosis drug
Vertex urged to address 'fatal inequality' in access to its cystic fibrosis drug
Beckers Hospital Review
Vertex Pharmaceuticals
cystic fibrosis
drug pricing
Flag link:
Corbus Pharma’s Lenabasum Fails Again, This Time in Cystic Fibrosis
Corbus Pharma’s Lenabasum Fails Again, This Time in Cystic Fibrosis
BioSpace
Corbus Pharma
lenabasum
cystic fibrosis
clinical trials
Flag link:
Vertex's Kalydeco Gets FDA Nod for Cystic Fibrosis in Infants
Vertex's Kalydeco Gets FDA Nod for Cystic Fibrosis in Infants
Yahoo/Zacks.com
Vertex Pharmaceuticals
Kalydeco
cystic fibrosis
Flag link:
Moderna lands $100M upfront in deals with Vertex, Chiesi
Moderna lands $100M upfront in deals with Vertex, Chiesi
Fierce Biotech
Moderna Therapeutics
cystic fibrosis
R&D
Vertex Pharmaceuticals
gene editing
Chiesi
Flag link:
Vertex's success kills off Savara's experimental cystic fibrosis drug hopes
Vertex's success kills off Savara's experimental cystic fibrosis drug hopes
Fierce Biotech
Savara
clinical trials
molgradex
cystic fibrosis
Flag link:
Tony Coles takes second neuroscience startup public as Yumanity reverse merges
Tony Coles takes second neuroscience startup public as Yumanity reverse merges
Endpoints
Tony Coles
Cerevel
Yumanity Therapeutics
cystic fibrosis
Proteostasis Therapeutics
Flag link:
Vertex : CHMP Grants Positive Opinion For KAFTRIO - KALYDECO In People Ages 12 And Older With CF
Vertex : CHMP Grants Positive Opinion For KAFTRIO - KALYDECO In People Ages 12 And Older With CF
Business Insider
Vertex Pharmaceuticals
Europe
EMA
CHMP
cystic fibrosis
Kalydeco
Kaftrio
Flag link:
Vertex's cystic fibrosis drugs work, but they're too expensive, ICER finds
Vertex's cystic fibrosis drugs work, but they're too expensive, ICER finds
Endpoints
Vertex Pharmaceuticals
drug pricing
cystic fibrosis
ICER
Flag link:
Arrowhead Pharmaceuticals files for regulatory clearance to begin phase 1/2a study of ARO-ENaC for treatment of cystic fibrosis
Arrowhead Pharmaceuticals files for regulatory clearance to begin phase 1/2a study of ARO-ENaC for treatment of cystic fibrosis
Pharmaceutical Business Review
Arrowhead Pharmaceuticals
clinical trials
cystic fibrosis
ARO-ENaC
RNAi
Flag link:
Coupling mRNA with tRNA and new delivery tech, MPM and OrbiMed help birth new $80M biotech into a slowed down world
Coupling mRNA with tRNA and new delivery tech, MPM and OrbiMed help birth new $80M biotech into a slowed down world
Endpoints
MPM
OrbiMed
TranscripTx
ReCode Therapeutics
cystic fibrosis
MRNA
tRNA
Flag link:
Eloxx cuts staff, CEO and shakes up leadership team
Eloxx cuts staff, CEO and shakes up leadership team
Fierce Biotech
Eloxx Pharmaceuticals
layoffs
cystic fibrosis
Flag link:
What's in Store for Vertex in 2020 After a Remarkable 2019?
What's in Store for Vertex in 2020 After a Remarkable 2019?
Yahoo/Zacks.com
Vertex Pharmaceuticals
cystic fibrosis
Orkambi
Kalydeco
Symdeko
Trikafta
Flag link:
Vertex impresses with strong Trikafta launch
Vertex impresses with strong Trikafta launch
BioPharma Dive
Vertex Pharmaceuticals
drug launches
cystic fibrosis
Trikafta
earnings
Flag link:
Novel Drug Candidate Aims To Tackle Superbug Infections In Cystic Fibrosis Patients
Novel Drug Candidate Aims To Tackle Superbug Infections In Cystic Fibrosis Patients
Forbes
cystic fibrosis
Antabio
superbugs
Flag link:
#JPM20: Vertex lays out post-CF ambitions as Gilead demurs on acquisition
#JPM20: Vertex lays out post-CF ambitions as Gilead demurs on acquisition
Endpoints
Vertex Pharmaceuticals
cystic fibrosis
JPMHC 2020
Gilead Sciences
M&A
Flag link:
Vertex’s triple therapy will reshape the landscape of cystic fibrosis trials
Vertex’s triple therapy will reshape the landscape of cystic fibrosis trials
BioCentury
Vertex Pharmaceuticals
FDA
cystic fibrosis
Trikafta
Flag link:
Cystic Fibrosis Foundation Licenses Experimental Compound to AbbVie
Cystic Fibrosis Foundation Licenses Experimental Compound to AbbVie
BioSpace
AbbVie
cystic fibrosis
drug development
Flag link:
After years of battling, Vertex and the U.K. reach a deal for cystic fibrosis medicines
After years of battling, Vertex and the U.K. reach a deal for cystic fibrosis medicines
Stat
Vertex Pharmaceuticals
cystic fibrosis
UK
Flag link:

Pages